On-demand Webinar: Controlling Impurities in Pharma Waters

Without proper impurity control, pharmaceutical manufacturers risk compromising the safety and efficacy of their products. Microbial and organic impurities can enter water systems at various points in the manufacturing process and impact quality and safety.

Misunderstandings surrounding controlling impurities in pharma waters can lead to improper measurement and treatment approaches.

It is a common belief that organic and microbiological contaminants in Water for Injection (WFI) and Purified Water (PW) are the same in pharmaceutical water systems. However, this is far from the truth. These contaminants react differently and, when found in storage and distribution loops, can have different effects on the health of the water system.

In this roundtable discussion, we dispel the most common myths about microbes and organics when controlling impurities in pharma waters. We discuss the differences between organic and microbiological contaminants in WFI and PW and recommend measurement approaches for each impurity type. Additionally, we cover how to maintain a healthy water loop to ensure high quality and safety in pharmaceutical manufacturing.

Presenter: Maura Rury - Senior Product Manager, METTLER TOLEDO Thornton

Joining Maura in the discussion are:

Anthony C. Bevilacqua - Principal Scientist, METTLER TOLEDO Thornton

Areen Kalantari - Global Segment Manager – Pharma & Life Sciences, METTLER TOLEDO Thornton